Nothing Special   »   [go: up one dir, main page]

KR950703952A - 부분 경화된 식물성 오일이 코팅된 시메티딘 과립(Cimetidine Granules Coated with a Partially Hydrogenated Vegetable Oil) - Google Patents

부분 경화된 식물성 오일이 코팅된 시메티딘 과립(Cimetidine Granules Coated with a Partially Hydrogenated Vegetable Oil)

Info

Publication number
KR950703952A
KR950703952A KR1019950702123A KR19950702123A KR950703952A KR 950703952 A KR950703952 A KR 950703952A KR 1019950702123 A KR1019950702123 A KR 1019950702123A KR 19950702123 A KR19950702123 A KR 19950702123A KR 950703952 A KR950703952 A KR 950703952A
Authority
KR
South Korea
Prior art keywords
cimetidine
vegetable oil
composition
pharmaceutical composition
partially cured
Prior art date
Application number
KR1019950702123A
Other languages
English (en)
Inventor
서쉴 샤우한
고든 프랜스
죤 뷰흘러
Original Assignee
데이비드 로버츠
스미스클라인 비참 피엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 데이비드 로버츠, 스미스클라인 비참 피엘씨 filed Critical 데이비드 로버츠
Publication of KR950703952A publication Critical patent/KR950703952A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 부분 경화된 식물성 오일이 코팅된 시메티딘 과립을 포함하는 제약조성물에 관한 것이다.

Description

부분 경화된 식물성 오일이 코팅된 시메티딘 과립(Cimetidine Granules Coated with a Partially Hydrogenated Vegetable Oil)
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 부분 경화된 식물성 오일 또는 그의 화학적 등가물이 시메티딘의 20중량% 이상에 해당하는 양으로 코팅된 시메티딘 과립을 포함하는 제약 조성물.
  2. 제1항에 있어서, 상기 부분 경화된 식물성 오일이 시메티딘의 50 내지 150중량% 바람직하게는 75 내지 125중량%의 양으로 존재하는 조성물.
  3. 제1또는 2항에 있어서, 상기 오일이 부분 경화된 면실유 또는 부분 경화된 대두유 또는 그의 혼합물인 조성물.
  4. 제1내지 3항 중 어느 한 항 기재의 코팅된 시메티딘 과립 및 현탁제를 포함하는 조제가능한 분말 제약 조성물.
  5. 제4항에 있어서, 계면활성제를 추가로 포함하는 조성물.
  6. 제5항에 있어서, 상기 계면활성제가 Tween 80인 조성물.
  7. 제1내지 저3항 중 어느 한 항 기재의 코팅된 시메티딘 과립을 포함하는 씹을 수 있는 정제.
  8. 제1내지 7항 중 어느 한 항에 있어서, 제산제를 추가로 포함하는 제약 조성물.
  9. 제1내지 8항 중 어느 한 항에 있어서, 알긴산염을 추가로 포함하는 제약 조성물.
  10. 제1내지 9항 중 어느 한 항에 있어서, 시메티콘을 추가로 포함하는 제약 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950702123A 1992-11-27 1993-11-22 부분 경화된 식물성 오일이 코팅된 시메티딘 과립(Cimetidine Granules Coated with a Partially Hydrogenated Vegetable Oil) KR950703952A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9224855.8 1992-11-27
GB929224855A GB9224855D0 (en) 1992-11-27 1992-11-27 Pharmaceutical compositions
PCT/EP1993/003272 WO1994012180A1 (en) 1992-11-27 1993-11-22 Cimetidine granules coated with a partially hydrogenated vegetable oil

Publications (1)

Publication Number Publication Date
KR950703952A true KR950703952A (ko) 1995-11-17

Family

ID=10725759

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950702123A KR950703952A (ko) 1992-11-27 1993-11-22 부분 경화된 식물성 오일이 코팅된 시메티딘 과립(Cimetidine Granules Coated with a Partially Hydrogenated Vegetable Oil)

Country Status (10)

Country Link
US (1) US5597844A (ko)
EP (1) EP0670722A1 (ko)
JP (1) JPH08503482A (ko)
KR (1) KR950703952A (ko)
CN (1) CN1095923A (ko)
AU (1) AU5563494A (ko)
CA (1) CA2149884A1 (ko)
GB (1) GB9224855D0 (ko)
WO (1) WO1994012180A1 (ko)
ZA (1) ZA938825B (ko)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0707484A4 (en) * 1993-07-06 1998-07-01 Merck & Co Inc ANTI-ACID-ALGINATE-ANTAGONIST H 2 COMBINATION?
US5808090A (en) * 1996-02-22 1998-09-15 Endo Pharmaceuticals Inc. Process for preventing precipitation in cimetidine injection solutions
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
WO1997047287A1 (fr) * 1996-06-14 1997-12-18 Kyowa Hakko Kogyo Co., Ltd. Comprime intra-oral a desintegration rapide
FR2753904B1 (fr) 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
US6242019B1 (en) 1997-08-14 2001-06-05 Warner-Lambert Company Taste modified hard confectionery compositions containing functional ingredients
DK1364584T3 (da) * 1997-08-14 2006-03-06 Cadbury Adams Usa Llc Smagsmodificerede hårde konfektionssammensætninger indeholdende funktionelle ingredienser
IN186245B (ko) * 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
ATE286721T1 (de) * 1997-09-19 2005-01-15 Shire Lab Inc Feste lösungskügelchen
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
WO1999033445A1 (en) * 1997-12-29 1999-07-08 The Procter & Gamble Company Tablet composition
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
FR2779651B1 (fr) 1998-06-16 2001-04-20 Gattefosse Ets Sa Procede pour la fabrication de comprimes a liberation prolongee de principe(s) actif(s) presentant une cinetique de dissolution d'ordre zero
EP1100466A1 (en) * 1998-07-31 2001-05-23 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical composition having improved taste
FR2784895B1 (fr) * 1998-10-23 2004-12-17 Gattefosse Ets Sa Comprime a croquer a gout masque et liberation immediate du principe actif et procede de fabrication
DE60017881T2 (de) 1999-04-06 2006-04-13 Ethypharm Trinkbare pharmazeutische suspension von ibuprofen
DE60005819T2 (de) * 1999-06-14 2004-05-06 Cosmo S.P.A. Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
WO2003034837A1 (en) * 2001-10-26 2003-05-01 John Kohnke Products Pty Ltd Dosage system & dosage vehicle therefor
AUPS244002A0 (en) 2002-05-20 2002-06-13 John Kohnke Products Pty Ltd Agent delivery system
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
PT1691787E (pt) * 2003-12-04 2008-09-02 Pfizer Prod Inc Método de formação de multipartículas farmacêuticas
EP1694304A2 (en) * 2003-12-04 2006-08-30 Pfizer Products Inc. Azithromycin multiparticulate dosage forms by liquid-based processes
CN1889931A (zh) * 2003-12-04 2007-01-03 辉瑞产品公司 利用挤压器制备优选含泊洛沙姆和甘油酯的多重粒子阿奇霉素组合物的喷雾－冻凝方法
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
JP2007513147A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 押し出し機を使用して、好ましくはポロキサマーとグリセリドを含有する多粒子結晶性医薬組成物を製造するための噴霧凝結方法
JP2007513139A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 安定性の改善した多粒子組成物
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
US20060105039A1 (en) 2004-10-21 2006-05-18 Jin-Wang Lai Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
GB0515492D0 (en) * 2005-07-28 2005-08-31 Reckitt Benckiser Healthcare Improvements in or relating to compositions,articles and methods
DE102006037298A1 (de) 2006-08-08 2008-02-14 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung, insbesondere Antazidum
RU2563623C2 (ru) 2009-12-02 2015-09-20 Апталис Фарма Лимитед Микрокапсулы фексофенадина и содержащие их композиции
WO2012049156A1 (en) * 2010-10-12 2012-04-19 Bayer Animal Health Gmbh Non-starch based soft chewables
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
JP6039042B1 (ja) 2015-11-20 2016-12-07 株式会社スクウェア・エニックス 描画処理プログラム、描画処理装置、描画処理方法、発音処理プログラム、発音処理装置、及び、発音処理方法
EP3528848A4 (en) * 2016-10-19 2020-07-15 Signpath Pharma Inc. PROTECTIVE EFFECT OF DMPC, DMPG, DMPC / DMPG, EGPG, LYSOPG AND LYSOPC AGAINST DRUGS CAUSING CANALOPATHIES
EP3534880B1 (en) * 2016-11-01 2022-05-18 Johnson & Johnson Consumer Inc. Liquid oral pharmaceutical dosage form comprising an histamine h2-receptor antagonist and an antacid
US20180140630A1 (en) * 2016-11-23 2018-05-24 M. Michael Wolfe Combination of an h2-receptor antagonist, antacid, and alginic acid to treat episodic heartburn
IT201800002625A1 (it) 2018-02-13 2019-08-13 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizione in forma solida per uso nel trattamento dei sintomi extra-esofagei del reflusso gastrico
US11141375B2 (en) 2018-10-18 2021-10-12 Johnson & Johnson Consumer Inc. Soft chewable dosage form

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960011236B1 (ko) * 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형
GB8730011D0 (en) * 1987-12-23 1988-02-03 Smithkline Dauelsberg Pharmaceutical compositions
AU8546591A (en) * 1990-09-13 1992-04-15 Smithkline Beecham Corporation Non-aqueous liquid oral suspensions
DE69233130T2 (de) * 1991-05-28 2005-06-02 Mcneil-Ppc, Inc. Kaubare zusammensetzung zur arzneimittelfreisetzung
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn

Also Published As

Publication number Publication date
ZA938825B (en) 1995-05-25
CN1095923A (zh) 1994-12-07
JPH08503482A (ja) 1996-04-16
GB9224855D0 (en) 1993-01-13
US5597844A (en) 1997-01-28
WO1994012180A1 (en) 1994-06-09
AU5563494A (en) 1994-06-22
EP0670722A1 (en) 1995-09-13
CA2149884A1 (en) 1994-06-09

Similar Documents

Publication Publication Date Title
KR950703952A (ko) 부분 경화된 식물성 오일이 코팅된 시메티딘 과립(Cimetidine Granules Coated with a Partially Hydrogenated Vegetable Oil)
KR840008264A (ko) 살서제 조성물
ATE53301T1 (de) Systeme zur verbesserung der durchdringungsfaehigkeit und deren zubereitung.
CA2207218A1 (en) Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure
CA2016968A1 (en) Air freshener composition
KR940008689A (ko) 항네프로제증후군제
ATE13898T1 (de) Chemische blaehmittelzusammensetzung, ihre herstellung und anwendung.
KR840000234A (ko) (n-아세틸-파라-아미노페놀)-제산제 조성물
ES1016349Y (es) Mamparo tubular.
AR001718A1 (es) Proceso para la producción de composiciones o componentes detergentes granulares
KR890011527A (ko) 살균성4,5-디클로로-1,2-디티올-3-온 조성물
JPS5324032A (en) Sublimable composition
KR920012407A (ko) 비누 조성물
ES2093740T4 (es) Formas de dosificacion solidas y estabilizadas de composiciones a base de salicilato de colina metal carboximetilcelulosa.
KR910011666A (ko) 모래를 주재로한 조성물
KR870008991A (ko) 시멘트 구조물의 균열보수용 코킹제
KR920002134A (ko) 분말분사형 에어졸 조성물
KR920006246A (ko) 온돌용 세라믹 조성물
KR930002268A (ko) 플라이 애쉬(Fly Ash)와 모래를 혼합한 시멘트 조성물
KR910700043A (ko) 타정시에 있어서 응력분산 방법
KR930004422A (ko) 고광택 코팅제의 제조방법
KR870000280A (ko) 아미노벤질아민 조성물
TH20310A (th) Cement composition
KR920011521A (ko) 소취제 조성물
KR920002751A (ko) 착화탄

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid